Market Cap 4.51B
Revenue (ttm) 1.53B
Net Income (ttm) 312.44M
EPS (ttm) N/A
PE Ratio 13.32
Forward PE 14.23
Profit Margin 20.37%
Debt to Equity Ratio 0.51
Volume 371,400
Avg Vol 1,266,654
Day's Range N/A - N/A
Shares Out 66.31M
Stochastic %K 70%
Beta -0.10
Analysts Strong Sell
Price Target $83.46

Company Profile

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area wi...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 978 671 8001
Fax: 978 671 8860
Address:
201 Burlington Road, South Building, Bedford, United States
RadioIsotope25
RadioIsotope25 Dec. 24 at 1:01 AM
When Aktis Oncology goes public in first quarter their market cap will be over a billion. They have 1 radiopharmaceutical in Phase 1 and a second preclinical for B7-H3.. Have over 132 million shares so if they issue $100 million at $10 we’re talking $1.4 billion market cap. Considering Radiopharm Theranostics has market cap of $66 million it would have 24x upside to reach their newly minted market cap. So what they have a deal with Lilly. $RADX has been getting money from $LNTH and and MD Anderson through Radiopharm Ventures. There using microproteins and RAD is using nanobodies. Plus RAD has a $500 million imaging agent in an unmet medical need. Rad is a no brainer with over a handful of clinical assets. $CATX
2 · Reply
osubuck30
osubuck30 Dec. 22 at 4:36 PM
$RADX would be hilarious if they termintate it now that the stock is below where $LNTH bought at last raise…. Talk about a short squeeze potential. Still crazy they manages to knock it all the way back below $5 with no meaningful bounce on lower and lower volume after how many shares traded on 12/15.
2 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 5:26 PM
Actionable Trade Alert for $LNTH: Market Context: $LNTH is currently trading at $64.84, showing bullish momentum with a recent close near the 60D high of $67.4. The RSI at 69.02 indicates the stock is nearing overbought territory, suggesting a potential pullback or consolidation phase. Directional Bias: The stock's price is above both the 30-day MA (58.3) and the 50-day MA (57.47), indicating a strong upward trend. However, the high RSI suggests caution. Trade Plan: - Suggested Entry: $64.84 - Stop Loss: $62.56 (approximately 3.5% below entry) - Take Profit Targets: 1. Target 1: $67.00 (3.3% gain) 2. Target 2: $70.00 (8.3% gain) 3. Target 3: $76.00 (17.3% gain) With these targets, a successful trade hitting all targets could yield over 17% ROI on Target 3. Monitor RSI for potential reversal signals. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 19 at 1:18 AM
$RADX There’s more buyers than companies available to be acquired in this space. $LNTH already owns 14.5%
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 2:33 PM
Truist Securities has updated their rating for Lantheus Holdings ( $LNTH ) to Buy with a price target of 82.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 3:05 PM
Mizuho updates rating for Lantheus Holdings ( $LNTH ) to Outperform, target set at 60 → 72.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 4:11 AM
Actionable Trade Alert for $LNTH: Market Context: $LNTH is currently trading at $65.17, near its 60D high of $67.4, indicating bullish momentum. The RSI at 69.52 suggests overbought conditions, but it can remain elevated in strong trends. Directional Bias: Given the price is above the MA30 (57.79) and MA50 (56.97), the trend is bullish. However, the high RSI indicates potential for a pullback before further gains. Trade Plan: - Suggested Entry: $65.50 (slightly above the last close to confirm strength) - Stop Loss: $62.00 (below recent support) - Take Profit Targets: 1. TP1: $68.00 (4% gain) 2. TP2: $70.00 (7% gain) 3. TP3: $76.00 (16.5% gain) This plan provides a solid risk-reward ratio, with TP3 offering over 17% ROI. Monitor for price action and adjust accordingly. https://privateprofiteers.com
0 · Reply
roaringcharts
roaringcharts Dec. 16 at 12:32 PM
$RADX $LNTH owns 13% here their market cap 4.5 billion
0 · Reply
roaringcharts
roaringcharts Dec. 16 at 12:01 PM
$RADX $LNTH is heavily invested here
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 7:44 AM
Actionable Trade Alert for $LNTH: Market Context: $LNTH closed at $66.62, near its 60D high of $67.35, indicating bullish momentum. The RSI of 80.96 suggests overbought conditions, which could lead to a pullback. However, strong upward movement is still present. Directional Bias: The stock is in a bullish trend, supported by the MA30 (57.22) and MA50 (56.47) being below the current price, indicating potential support levels. The recent high-low range (60D High: $67.35, Low: $49.67) suggests room for upward movement, but caution is warranted due to high RSI. Trade Plan: - Suggested Entry: $66.50 - Stop Loss: $64.00 (risking $2.50) - Take Profit Targets: 1. TP1: $68.00 (2.25% gain) 2. TP2: $70.00 (5.25% gain) 3. TP3: $78.00 (17.16% gain) This trade plan offers a solid risk-reward ratio with a potential 17% ROI on TP3. Monitor RSI and market conditions for adjustments. https://privateprofiteers.com
0 · Reply
Latest News on LNTH
Lantheus Holdings, Inc. (LNTH) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 9:09 PM EDT - 5 months ago

Lantheus Holdings, Inc. (LNTH) Q2 2025 Earnings Call Transcript


Lantheus Holdings: Reassessing The Buy Thesis

Aug 6, 2025, 10:09 AM EDT - 5 months ago

Lantheus Holdings: Reassessing The Buy Thesis


RadioIsotope25
RadioIsotope25 Dec. 24 at 1:01 AM
When Aktis Oncology goes public in first quarter their market cap will be over a billion. They have 1 radiopharmaceutical in Phase 1 and a second preclinical for B7-H3.. Have over 132 million shares so if they issue $100 million at $10 we’re talking $1.4 billion market cap. Considering Radiopharm Theranostics has market cap of $66 million it would have 24x upside to reach their newly minted market cap. So what they have a deal with Lilly. $RADX has been getting money from $LNTH and and MD Anderson through Radiopharm Ventures. There using microproteins and RAD is using nanobodies. Plus RAD has a $500 million imaging agent in an unmet medical need. Rad is a no brainer with over a handful of clinical assets. $CATX
2 · Reply
osubuck30
osubuck30 Dec. 22 at 4:36 PM
$RADX would be hilarious if they termintate it now that the stock is below where $LNTH bought at last raise…. Talk about a short squeeze potential. Still crazy they manages to knock it all the way back below $5 with no meaningful bounce on lower and lower volume after how many shares traded on 12/15.
2 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 19 at 5:26 PM
Actionable Trade Alert for $LNTH: Market Context: $LNTH is currently trading at $64.84, showing bullish momentum with a recent close near the 60D high of $67.4. The RSI at 69.02 indicates the stock is nearing overbought territory, suggesting a potential pullback or consolidation phase. Directional Bias: The stock's price is above both the 30-day MA (58.3) and the 50-day MA (57.47), indicating a strong upward trend. However, the high RSI suggests caution. Trade Plan: - Suggested Entry: $64.84 - Stop Loss: $62.56 (approximately 3.5% below entry) - Take Profit Targets: 1. Target 1: $67.00 (3.3% gain) 2. Target 2: $70.00 (8.3% gain) 3. Target 3: $76.00 (17.3% gain) With these targets, a successful trade hitting all targets could yield over 17% ROI on Target 3. Monitor RSI for potential reversal signals. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 19 at 1:18 AM
$RADX There’s more buyers than companies available to be acquired in this space. $LNTH already owns 14.5%
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 2:33 PM
Truist Securities has updated their rating for Lantheus Holdings ( $LNTH ) to Buy with a price target of 82.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 3:05 PM
Mizuho updates rating for Lantheus Holdings ( $LNTH ) to Outperform, target set at 60 → 72.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 17 at 4:11 AM
Actionable Trade Alert for $LNTH: Market Context: $LNTH is currently trading at $65.17, near its 60D high of $67.4, indicating bullish momentum. The RSI at 69.52 suggests overbought conditions, but it can remain elevated in strong trends. Directional Bias: Given the price is above the MA30 (57.79) and MA50 (56.97), the trend is bullish. However, the high RSI indicates potential for a pullback before further gains. Trade Plan: - Suggested Entry: $65.50 (slightly above the last close to confirm strength) - Stop Loss: $62.00 (below recent support) - Take Profit Targets: 1. TP1: $68.00 (4% gain) 2. TP2: $70.00 (7% gain) 3. TP3: $76.00 (16.5% gain) This plan provides a solid risk-reward ratio, with TP3 offering over 17% ROI. Monitor for price action and adjust accordingly. https://privateprofiteers.com
0 · Reply
roaringcharts
roaringcharts Dec. 16 at 12:32 PM
$RADX $LNTH owns 13% here their market cap 4.5 billion
0 · Reply
roaringcharts
roaringcharts Dec. 16 at 12:01 PM
$RADX $LNTH is heavily invested here
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 15 at 7:44 AM
Actionable Trade Alert for $LNTH: Market Context: $LNTH closed at $66.62, near its 60D high of $67.35, indicating bullish momentum. The RSI of 80.96 suggests overbought conditions, which could lead to a pullback. However, strong upward movement is still present. Directional Bias: The stock is in a bullish trend, supported by the MA30 (57.22) and MA50 (56.47) being below the current price, indicating potential support levels. The recent high-low range (60D High: $67.35, Low: $49.67) suggests room for upward movement, but caution is warranted due to high RSI. Trade Plan: - Suggested Entry: $66.50 - Stop Loss: $64.00 (risking $2.50) - Take Profit Targets: 1. TP1: $68.00 (2.25% gain) 2. TP2: $70.00 (5.25% gain) 3. TP3: $78.00 (17.16% gain) This trade plan offers a solid risk-reward ratio with a potential 17% ROI on TP3. Monitor RSI and market conditions for adjustments. https://privateprofiteers.com
0 · Reply
RadioIsotope25
RadioIsotope25 Dec. 14 at 11:00 PM
$RADX Great data on RAD101 met primary endpoint at 92% $CAPR $LNTH $IMNM $PYXS
1 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Dec. 14 at 1:12 AM
$LNTH going to $300 next year
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Dec. 13 at 11:01 AM
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Dec. 13 at 1:05 AM
0 · Reply
Cmhatwell
Cmhatwell Dec. 12 at 5:41 PM
$GRI So peeved at myself over this. $BCRX wtf $LNTH lfg babt
1 · Reply
DaPod
DaPod Dec. 12 at 3:37 PM
$LNTH Good to see the interest in the past few days and the buying moving the price up. Actually LNTH started showing shares being bought in early November after a drop to 50 area. Wondering how much buying is the company's stock purchase plan? Feel thy have bought but also feel other buyers are active. One tech service shows LNTH breaking $65.94 makes $75.02 next resistance. If you remember LNTH past trading history you will know that the stock can move both quickly and gain a good percentage in a short time!! I hate to mention this as we hear it too often on various stocks, but have and do feel LNTH could be a very good acquisition for another imaging or drug company. Also, cannot help but wonder what LNTH might be worth if their imaging agent is successful in detecting Alzheimer's disease. Never hurts to hope!!
0 · Reply
MaverikIT
MaverikIT Dec. 12 at 2:58 PM
$LNTH nice pop$ with upgrd
0 · Reply
JarvisFlow
JarvisFlow Dec. 12 at 2:44 PM
Truist Securities updates rating for Lantheus Holdings ( $LNTH ) to Buy, target set at 61 → 80.
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 12 at 12:38 AM
Actionable Trade Alert for $LNTH: Market Context: $LNTH is currently experiencing strong bullish momentum, closing at $62.01. The RSI at 77.95 indicates overbought conditions, suggesting potential for a pullback. However, the price is above both the 30-day (MA30) and 50-day (MA50) moving averages, signaling a strong upward trend. Directional Bias: The bullish trend is supported by the recent high of $64.4, which is within reach. The distance from the current price to the 60-day low of $49.67 provides a favorable risk-reward ratio. Trade Plan: - Suggested Entry: $62.01 - Stop Loss: $59.84 (below recent support, approximately 3.5% risk) - Take Profit Targets: 1. $64.00 (3.2% gain) 2. $66.00 (6.4% gain) 3. $72.50 (16.8% gain) With the third target providing a potential ROI of 16.8%, this trade plan offers a solid opportunity for profit while managing risk effectively. https://privateprofiteers.com
0 · Reply
CharlieeMungerTWITS
CharlieeMungerTWITS Dec. 10 at 11:02 PM
$LNTH LETS GOOOO
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 10 at 6:27 PM
$LNTH Current Stock Price: $60.39 Contracts to trade: $60 LNTH Dec 19 2025 Call Entry: $1.80 Exit: $2.76 ROI: 53% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 4:41 AM
Actionable Trade Alert for $LNTH: Market Context: $LNTH is currently trading at $60.88, showing strong momentum but is approaching overbought territory with an RSI of 74.09. The stock is above its 30-day MA of 56.49 and 50-day MA of 55.77, indicating bullish sentiment. The 60-day high of 64.4 suggests potential resistance ahead. Directional Bias: Given the high RSI and proximity to the 60-day high, we anticipate a pullback before a potential breakout. However, the overall trend remains bullish due to the price being above key moving averages. Trade Plan: - Suggested Entry: $60.88 - Stop Loss: $58.00 (3.8% risk) - Take Profit Targets: 1. $63.00 (3.5% gain) 2. $65.00 (6.5% gain) 3. $71.00 (16.7% gain) This plan offers a minimum of 16.7% ROI on the third target, aligning with our goal. Monitor for volatility given the ATR of 2.2. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply